<?xml version="1.0" encoding="UTF-8"?>
<ref id="B92-medicina-57-00217">
 <label>92.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gendrot</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Duflot</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Boxberger</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Delandre</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Jardot</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Le Bideau</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Andreani</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Fonta</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Mosnier</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Rolland</surname>
    <given-names>C.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate</article-title>
  <source>Int J. Infect. Dis.</source>
  <year>2020</year>
  <volume>99</volume>
  <fpage>437</fpage>
  <lpage>440</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ijid.2020.08.032</pub-id>
  <?supplied-pmid 32805422?>
  <pub-id pub-id-type="pmid">32805422</pub-id>
 </element-citation>
</ref>
